Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-03-10 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
独立董事对公司对外担保情况的专项说明
Audit Report / Information Classification · 90% confidence The document is a special statement by independent directors regarding the company's external guarantees during the 2021 fiscal year. It references regulatory requirements from the China Securities Regulatory Commission and discusses compliance with laws and company articles. The document is short (803 characters) and focuses on a specific governance-related topic rather than presenting full financial data or audit results. It is not an annual report, audit report, or financial statement. Instead, it is a standalone statement related to governance and compliance on external guarantees, which fits best under Audit Report / Information (AR) as it involves an independent directors' review and opinion on a specific regulatory compliance matter.
2022-03-10 Chinese
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled as an "Investor Relations Management System" for Shenzhen Huitai Medical Devices Co., Ltd. It outlines principles, organizational structure, and procedures for managing investor relations, including communication with investors, handling complaints, and ensuring compliance with laws and regulations. There are no financial statements, earnings data, or regulatory filings of financial results. The content is focused on governance and management of investor relations rather than financial reporting or announcements. It is a policy or governance document related to investor relations management practices. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 3603 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2022-03-10 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled "信息披露管理制度" (Information Disclosure Management System) of Shenzhen Huitai Medical Devices Co., Ltd. It outlines the principles, procedures, responsibilities, and legal requirements for information disclosure by the company. It references various regulatory frameworks such as the Chinese Company Law, Securities Law, Shanghai Stock Exchange rules, and China Securities Regulatory Commission regulations. The document covers definitions of major information, disclosure obligations, types of reports (annual, interim, and temporary), disclosure procedures, management responsibilities, and legal liabilities related to information disclosure. It does not contain actual financial statements, earnings data, audit opinions, or specific event announcements. Instead, it is a governance and compliance manual for managing information disclosure. Therefore, it fits best under Governance Information (CGR), which includes reports detailing the company's internal rules, board structure, and governance practices related to disclosure and compliance.
2022-03-10 Chinese
2021年度非经营性资金占用及其他关联资金往来情况的专项报告
Audit Report / Information Classification · 95% confidence The document is a specialized report titled '非经营性资金占用及其他关联资金往来情况的专项报告' for the fiscal year 2021, issued by Shenzhen Huitai Medical Device Co., Ltd. It includes audit information, references to audited financial statements, and is prepared in accordance with regulatory guidelines from the China Securities Regulatory Commission and Shanghai Stock Exchange. The report is issued by a certified public accounting firm and signed by auditors, indicating it is a standalone audit-related report focusing on non-operating fund occupation and related party transactions. It is not a full annual report (10-K), nor is it a brief announcement or a certification letter. The content and length (8718 characters) support it being a detailed audit report or special audit information. Therefore, the most appropriate classification is Audit Report / Information (AR).
2022-03-10 Chinese
独立董事关于第一届董事会第十六次会议相关议案的事前认可意见
Board/Management Information Classification · 90% confidence The document is a statement from independent directors providing their prior approval opinions on proposals related to the company's board meeting, specifically regarding the appointment of the 2022 audit firm. It references regulatory guidelines for independent directors and audit firm qualifications. The document does not contain actual financial statements or detailed audit reports but is an opinion or approval related to audit matters. It is not a full audit report or annual report but rather a governance-related document expressing independent directors' views on audit firm appointment. Therefore, it fits best under Board/Management Information (MANG), which covers announcements related to board matters and management decisions.
2022-03-10 Chinese
关联交易管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled "关联交易管理制度" (Related Party Transaction Management System) of Shenzhen Huitai Medical Equipment Co., Ltd. It outlines principles, definitions, procedures, decision-making authority, disclosure, and responsibilities related to related party transactions. It references regulatory frameworks such as the Shanghai Stock Exchange rules and the China Securities Regulatory Commission, but it is not a financial report, audit report, or announcement. It is a governance document detailing internal rules and procedures for managing related party transactions, including board and shareholder meeting roles, pricing principles, and disclosure requirements. It does not contain financial statements or earnings data, nor is it a meeting presentation or voting result announcement. Therefore, it fits best under Governance Information (CGR). The document length and detail confirm it is the policy itself, not an announcement or summary.
2022-03-10 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.